Landmarks in the diagnosis and treatment of renal cell carcinoma.
about
The PI3K/AKT Pathway and Renal Cell CarcinomaInhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressivenessAn increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinomaDNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinomaDecreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinomaCyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisNuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.Apigenin inhibits renal cell carcinoma cell proliferationTransarterial embolization of renal tumors improves surgical outcomes: A case series.A river model to map convergent cancer evolution and guide therapy in RCC.Simple Enucleation for Renal Tumors: Indications, Techniques, and Results.PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma.GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma.Presurgical neoadjuvant targeted molecular therapy for kidney cancer with concomitant vena cava tumor embolus: A clinical study.Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.Lower mean platelet volume predicts poor prognosis in renal cell carcinoma.RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma.Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma.The current status of immunobased therapies for metastatic renal-cell carcinoma.Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.Biomarker discovery for renal cancer stem cells.The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning.Epidemiology and screening for renal cancerCorrelation of T Cell Immunoglobulin and ITIM Domain (TIGIT) and Programmed Death 1 (PD-1) with Clinicopathological Characteristics of Renal Cell Carcinoma May Indicate Potential Targets for Treatment
P2860
Q26800216-EEB7C54E-06ED-48B4-9B50-8BF3B690A02DQ27304863-5FC492FD-6706-4974-B597-B1864F9400D3Q33704636-F8294164-CE9B-41E3-A78B-1917D418ECF2Q33730811-E210D8D0-18F0-4CAC-8C84-D531D8BD822EQ34694198-26A1AE8D-EB1E-4063-913F-53E5C51324B6Q35585683-4FC02C25-9534-4B64-800C-7C17D03E4A4BQ35741006-3E5C654E-A3C9-4A53-9CFB-31C5BB4EDA71Q36170317-280C820A-7249-471F-9CB3-1C23DD4BF25DQ36367103-204B8BC3-354D-4A12-9B82-03C801C3977DQ37421650-FA4EF4AF-A362-40DA-9700-CBE8D3790730Q37437381-0DAB3C1E-5BC4-452D-BEB0-3FCC829F8047Q37701482-6C1AC2DA-ABF5-44E8-AD80-940C2E4FB9A7Q37746158-D804DC47-2EAB-40F8-9CC0-D2E24A2BF6A1Q38580646-A3BDF7D6-E2F2-4ED5-B142-4C677F3E1401Q38622920-70545422-FB3A-4420-89B5-CC908D560F33Q38686146-4AEC2C50-50FB-45AF-9CBE-4CD1900B1046Q38788703-FEDCB729-E525-4CAC-A0BF-7E252504C2CCQ38853863-E90FB977-EBE6-48AE-874A-FDD98CE5F446Q39146606-73B8FC03-A4B0-4641-BE94-3EC3B3F07101Q40977445-E12E6842-7C51-48DB-9549-24DA9EDB0D37Q41098262-83ADAE23-FC2F-477B-AB10-8290099CEDF8Q41159136-F2C533FE-3C63-404A-8538-D78E8A9A1C3CQ41247591-B3309391-0FDE-49DD-B834-7EDAF660F4E8Q41979607-9D87FAE8-21B9-4BFD-8E3B-9E8AC5B0F095Q42775763-39C28715-9EF2-4377-908E-87A07516C08CQ47097756-A7AD85D7-0625-465B-816D-1E17588FB05EQ47245393-80548ECF-708F-44EA-84B9-323B98C52210Q49425132-0C11BD82-0BB4-49D1-8960-CCE1E953154CQ49668843-807CDE6F-446F-474C-91B5-33F1C426D706Q50049701-E13F9B84-47C1-4502-BD82-13C929747436Q50141378-86F829C0-4F1B-4805-97A4-A72AC9F29409Q51546681-E523D896-CAC6-4FA2-B18D-82D755370C25Q51854381-EA1B3C70-A386-4E6A-AB0D-14C2640BF806Q52879568-9C853EE1-F033-4B9A-810E-7CBB79A95149Q52951714-495482E3-96EF-4602-9E92-A05776EF0CBCQ55242404-244FC426-16B0-4DA5-9825-3901896DC8B6Q57640122-7EA20BB1-B303-477E-AECC-C49D07BECD7DQ58796432-5E18397B-EF7A-4C43-AA76-27B3123EEF78
P2860
Landmarks in the diagnosis and treatment of renal cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Landmarks in the diagnosis and treatment of renal cell carcinoma.
@en
type
label
Landmarks in the diagnosis and treatment of renal cell carcinoma.
@en
prefLabel
Landmarks in the diagnosis and treatment of renal cell carcinoma.
@en
P2860
P356
P1476
Landmarks in the diagnosis and treatment of renal cell carcinoma.
@en
P2093
Antonio Finelli
Jaimin R Bhatt
P2860
P2888
P304
P356
10.1038/NRUROL.2014.194
P407
P577
2014-08-12T00:00:00Z
P6179
1053411665